Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073879
Status:
COMPLETED
Last Update Posted:
2015-01-29
First Post:
2003-12-10
Brief Title:
Fludarabine Cyclophosphamide and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma Kidney Cancer Undergoing Allogeneic Stem Cell Transplantation
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Organization Data
Organization:
Baylor College of Medicine
Class:
OTHER
Study ID:
CDR0000328247
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Helen Heslop
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Baylor College of Medicine
Old Name:
None
Old Organization:
None